Taro Announces Joining of CEO
September 01 2017 - 4:05PM
Business Wire
Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the
“Company”) announced today that Mr. Uday Baldota has joined the
Company as its Chief Executive Officer (“CEO”) effective August 28,
2017. Since December 2016, Mr. Baldota has served as a member of
Taro’s Board of Directors (“Taro Board”).
Mr. Baldota replaces Mr. Abhay Gandhi, who served in the role of
Interim Chief Executive Officer since January 1, 2017. Mr. Gandhi
will continue in his role as Vice Chairman of the Taro Board and as
the CEO of the Sun Pharma North America operations.
About Taro
Taro Pharmaceutical Industries Ltd. is a multinational,
science-based pharmaceutical company, dedicated to meeting the
needs of its customers through the discovery, development,
manufacturing and marketing of the highest quality healthcare
products. For further information on Taro Pharmaceutical Industries
Ltd., please visit the Company’s website at www.taro.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170901005726/en/
Taro Pharmaceutical Industries Ltd.Mariano Balaguer,
914-345-9001VP, Chief Financial
OfficerMariano.Balaguer@taro.comorWilliam J. Coote,
914-345-9001AVP, Business Finance, Treasurer and Investor
RelationsWilliam.Coote@taro.com
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Mar 2024 to Apr 2024
Taro Pharmaceutical Indu... (NYSE:TARO)
Historical Stock Chart
From Apr 2023 to Apr 2024